333

VUNO, INC.

No trades
See on Supercharts

338220 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

VUNO, Inc. engages in the development of development of artificial intelligence based medical solutions. It offers diagnostic support decision tools and systems such as bone age assessment tool, chest x-ray, pulmonary lung nodule detection and reporting system, eye fundus screening solution, neuro degenerative disease quantification tool, and cardiac activity warning system. The company was founded by Ye-Ha Lee, Hyun-Jun Kim, and Kyu-Hwan Jung on December 10, 2014 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

338220 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company